Emcure Pharmaceuticals IPO targets ₹1,952 crore.
Strategic financial leapEmcure Pharmaceuticals, a leading Pune-based pharmaceutical business, aims to raise ₹1,952 crore through an IPO. The IPO will open for subscription on July 3, 2024, offering 7.9 million equity shares worth ₹800 crore and an OFS of 11.4 million shares worth ₹1,152.03 crore. IPO Details and PriceThe IPO’s price range is ₹960 to…